Gan & Lee Pharmaceuticals 2025 SR

The report highlights Gan & Lee Pharmaceuticals' sustainability practices and performance for the fiscal year 2025. As the company's inaugural ESG report, it outlines key achievements, including a 32% reduction in greenhouse gas emission intensity compared to 2023 and the successful integration of green power, which reached over 28 million kWh. The company also advanced its global healthcare access by securing a positive opinion from the EMA's CHMP for its self-developed insulin glargine biosimilar. Additionally, Gan & Lee demonstrated strong social commitment through rural revitalization efforts and a personal RMB 100 million donation by its founder to support scientific research and education.

Company: Gan & Lee Pharmaceuticals

Sector: Health Care

Country: China

Year: 2025

Type: SR

Pages: 60

Back to company

Gan & Lee Pharmaceuticals

Gan & Lee Pharmaceuticals 2025 Environmental, Social and Governance Report

Environmental, Social And Governance Report

The report highlights Gan & Lee Pharmaceuticals' sustainability practices and performance for the fiscal year 2025. As the company's inaugural ESG report, it outlines key achievements, including a 32% reduction in greenhouse gas emission intensity compared to 2023 and the successful integration of green power, which reached over 28 million kWh. The company also advanced its global healthcare access by securing a positive opinion from the EMA's CHMP for its self-developed insulin glargine biosimilar. Additionally, Gan & Lee demonstrated strong social commitment through rural revitalization efforts and a personal RMB 100 million donation by its founder to support scientific research and education.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2025

Reporting Period

Jan 1, 2025 - Dec 31, 2025

Fiscal Year

2025

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Women on Board

Women in Management